IL6 and lung adenocarcinoma: Network analysis in non-smoking female lung adenocarcinoma patients described IL-6 as one of the pathology’s central nodes [16], and these findings agree with our results, which provide evidence of the critical role of IL-6 in tumor progression in female lung adenocarcinoma patients.